These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25335493)

  • 21. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.
    Smith MJ; Bowers NL; Bulman M; Gokhale C; Wallace AJ; King AT; Lloyd SK; Rutherford SA; Hammerbeck-Ward CL; Freeman SR; Evans DG
    Neurology; 2017 Jan; 88(1):87-92. PubMed ID: 27856782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifocal nerve lesions and LZTR1 germline mutations in segmental schwannomatosis.
    Farschtschi S; Mautner VF; Pham M; Nguyen R; Kehrer-Sawatzki H; Hutter S; Friedrich RE; Schulz A; Morrison H; Jones DT; Bendszus M; Bäumer P
    Ann Neurol; 2016 Oct; 80(4):625-8. PubMed ID: 27472264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted massively parallel sequencing of candidate regions on chromosome 22q predisposing to multiple schwannomas: An analysis of 51 individuals in a single-center experience.
    Piotrowski A; Koczkowska M; Poplawski AB; Bartoszewski R; Króliczewski J; Mieczkowska A; Gomes A; Crowley MR; Crossman DK; Chen Y; Lao P; Serra E; Llach MC; Castellanos E; Messiaen LM
    Hum Mutat; 2022 Jan; 43(1):74-84. PubMed ID: 34747535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.
    Rousseau G; Noguchi T; Bourdon V; Sobol H; Olschwang S
    BMC Neurol; 2011 Jan; 11():9. PubMed ID: 21255467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis.
    Tunkel AE; Youner ER; Barseghyan H; Fu Y; Bhattacharya S; Bornhorst M; Monfared AS
    Am J Clin Pathol; 2024 Aug; 162(2):110-114. PubMed ID: 38527168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis.
    Gossai N; Biegel JA; Messiaen L; Berry SA; Moertel CL
    Am J Med Genet A; 2015 Dec; 167A(12):3186-91. PubMed ID: 26364901
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Forde C; Smith MJ; Burghel GJ; Bowers N; Roberts N; Lavin T; Halliday J; King AT; Rutherford S; Pathmanaban ON; Lloyd S; Freeman S; Halliday D; Parry A; Axon P; Buttimore J; Afridi S; Obholzer R; Laitt R; Thomas O; Stivaros SM; Vassallo G; Evans DG
    J Med Genet; 2024 Aug; 61(9):856-860. PubMed ID: 38925914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
    Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Druker H; Scott HS; Tabori U
    Clin Cancer Res; 2017 Jun; 23(12):e54-e61. PubMed ID: 28620005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
    Hadfield KD; Newman WG; Bowers NL; Wallace A; Bolger C; Colley A; McCann E; Trump D; Prescott T; Evans DG
    J Med Genet; 2008 Jun; 45(6):332-9. PubMed ID: 18285426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.
    Plotkin SR; Blakeley JO; Evans DG; Hanemann CO; Hulsebos TJ; Hunter-Schaedle K; Kalpana GV; Korf B; Messiaen L; Papi L; Ratner N; Sherman LS; Smith MJ; Stemmer-Rachamimov AO; Vitte J; Giovannini M
    Am J Med Genet A; 2013 Mar; 161A(3):405-16. PubMed ID: 23401320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of potential novel candidate genes in schwannomatosis patients.
    Perez-Becerril C; Wallace AJ; Schlecht H; Bowers NL; Smith PT; Gokhale C; Eaton H; Charlton C; Robinson R; Charlton RS; Evans DG; Smith MJ
    Hum Mutat; 2022 Oct; 43(10):1368-1376. PubMed ID: 35723634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
    Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.
    Mansouri S; Suppiah S; Mamatjan Y; Paganini I; Liu JC; Karimi S; Patil V; Nassiri F; Singh O; Sundaravadanam Y; Rath P; Sestini R; Gensini F; Agnihotri S; Blakeley J; Ostrow K; Largaespada D; Plotkin SR; Stemmer-Rachamimov A; Ferrer MM; Pugh TJ; Aldape KD; Papi L; Zadeh G
    Acta Neuropathol; 2021 Jan; 141(1):101-116. PubMed ID: 33025139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.
    Smith MJ; Kulkarni A; Rustad C; Bowers NL; Wallace AJ; Holder SE; Heiberg A; Ramsden RT; Evans DG
    Am J Med Genet A; 2012 Jan; 158A(1):215-9. PubMed ID: 22105938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors.
    Smith MJ; Wallace AJ; Bowers NL; Eaton H; Evans DG
    Cancer Genet; 2014 Sep; 207(9):373-8. PubMed ID: 24933152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous Detection of
    Bianchessi D; Ibba MC; Saletti V; Blasa S; Langella T; Paterra R; Cagnoli GA; Melloni G; Scuvera G; Natacci F; Cesaretti C; Finocchiaro G; Eoli M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32575496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.
    Smith MJ; Wallace AJ; Bowers NL; Rustad CF; Woods CG; Leschziner GD; Ferner RE; Evans DG
    Neurogenetics; 2012 May; 13(2):141-5. PubMed ID: 22434358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Segmental schwannomatosis: characteristics in 12 patients.
    Alaidarous A; Parfait B; Ferkal S; Cohen J; Wolkenstein P; Mazereeuw-Hautier J
    Orphanet J Rare Dis; 2019 Aug; 14(1):207. PubMed ID: 31438995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
    Sestini R; Bacci C; Provenzano A; Genuardi M; Papi L
    Hum Mutat; 2008 Feb; 29(2):227-31. PubMed ID: 18072270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas.
    Patil S; Perry A; Maccollin M; Dong S; Betensky RA; Yeh TH; Gutmann DH; Stemmer-Rachamimov AO
    Brain Pathol; 2008 Oct; 18(4):517-9. PubMed ID: 18422762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.